Cargando…

Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome

BACKGROUND: Osteogenesis Imperfecta (OI) (OMIM %259450) is a heterogeneous group of inherited disorders characterized by increased bone fragility, with clinical severity ranging from mild to lethal. The majority of OI cases are caused by mutations in COL1A1 or COL1A2. Bruck Syndrome (BS) is a furthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneto, Carla M., Lima, Patrícia S. P., Zanette, Dalila Lucíola, Oliveira, Thiago Yukio Kikuchi, de Assis Pereira, Francisco, Lorenzi, Julio Cesar Cetrulo, dos Santos, Jane Lima, Prata, Karen L., Neto, João M. Pina, de Paula, Francisco J. A., Silva, Wilson A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857408/ https://www.ncbi.nlm.nih.gov/pubmed/27146342 http://dx.doi.org/10.1186/s12881-016-0301-7

Ejemplares similares

COL1A1 and miR-29b show lower expression levels during osteoblast differentiation of bone marrow stromal cells from Osteogenesis Imperfecta patients
por: Kaneto, Carla M, et al.
Publicado: (2014)

Simvastatin Modulates Mesenchymal Stromal Cell Proliferation and Gene Expression
por: Zanette, Dalila Lucíola, et al.
Publicado: (2015)

Das Brücke-Museum Berlin /
por: Moeller, Magdalena M.

Kybernetik: Brücke zwischen den Wissenschaften
por: Hassenstein, B, et al.
Publicado: (1964)

A Brücke–Bartley effect for contrast
por: Solomon, Joshua A., et al.
Publicado: (2018)

Highly expressed placental miRNAs control key biological processes in human cancer cell lines
por: Vidal, Daniel Onofre, et al.
Publicado: (2018)

Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line
por: Muys, Bruna Rodrigues, et al.
Publicado: (2016)

Die Einstein-Rosen-Brücke: unterwegs zu außerirdischer Intelligenz
por: Johannes von Buttlar
Publicado: (1982)

On a conjecture of R. Brück and some linear differential equations
por: Xu, Hong Yan, et al.
Publicado: (2015)

Mutations in FKBP10 Cause Recessive Osteogenesis Imperfecta and Bruck Syndrome
por: Kelley, Brian P, et al.
Publicado: (2011)

A Rare Case of Bruck Syndrome Type 2 in Siblings With Broad Phenotypic Variability
por: Luce, Lindsey, et al.
Publicado: (2020)

Novel Mutations in FKBP10 and PLOD2 Cause Rare Bruck Syndrome in Chinese Patients
por: Zhou, Peiran, et al.
Publicado: (2014)

Orthopedic Manifestations of Bruck Syndrome: A Case Series with Intermediate to Long-term Follow-Up
por: Santana, Adolfredo, et al.
Publicado: (2019)

Genetic Analysis and Functional Study of a Pedigree With Bruck Syndrome Caused by PLOD2 Variant
por: Wang, Ruo-li, et al.
Publicado: (2022)

Abnormal Bone Collagen Cross‐Linking in Osteogenesis Imperfecta/Bruck Syndrome Caused by Compound Heterozygous PLOD2 Mutations
por: Gistelinck, Charlotte, et al.
Publicado: (2021)

Sex and Genetic Factors Determine Osteoblastic Differentiation Potential of Murine Bone Marrow Stromal Cells
por: Zanotti, Stefano, et al.
Publicado: (2014)

Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling
por: Quarato, Emily R., et al.
Publicado: (2023)

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
por: Id Boufker, Hichame, et al.
Publicado: (2010)

Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation
por: Li, J, et al.
Publicado: (2013)

Case Report: Exome Sequencing Identified a Novel Compound Heterozygous Variation in PLOD2 Causing Bruck Syndrome Type 2
por: Zhang, Jing, et al.
Publicado: (2021)

A cost-effective method to enhance adenoviral transduction of primary murine osteoblasts and bone marrow stromal cells
por: Buo, Atum M, et al.
Publicado: (2016)

The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells
por: Tsubaki, Masanobu, et al.
Publicado: (2020)

Untargeted metabolomics in primary murine bone marrow stromal cells reveals distinct profile throughout osteoblast differentiation
por: Misra, Biswapriya B., et al.
Publicado: (2021)

Osteoblasts and Bone Marrow Mesenchymal Stromal Cells Control Hematopoietic Stem Cell Migration and Proliferation in 3D In Vitro Model
por: de Barros, Ana Paula D. N., et al.
Publicado: (2010)

Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
por: Marin, Anelis Maria, et al.
Publicado: (2023)

Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation
por: Ghali, Olfa, et al.
Publicado: (2015)

Commentary: A Cost-Effective Method to Enhance Adenoviral Transduction of Primary Murine Osteoblasts and Bone Marrow Stromal Cells
por: Sharma, Aikta, et al.
Publicado: (2020)

SPARC is a decoy counterpart for c‑Fos and is associated with osteoblastic differentiation of bone marrow stromal cells by inhibiting adipogenesis
por: Hatori, Tomoya, et al.
Publicado: (2023)

Immunostaining of stromal CD56 cells in ovarian malignancies
por: de Lima, Cid Almeida, et al.
Publicado: (2023)

Collagenase Impacts the Quantity and Quality of Native Mesenchymal Stem/Stromal Cells Derived during Processing of Umbilical Cord Tissue
por: Taghizadeh, Rouzbeh R., et al.
Publicado: (2018)

Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
por: Rellick, Stephanie L., et al.
Publicado: (2012)

Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?
por: da Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)

Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients
por: Marin, Anelis Maria, et al.
Publicado: (2022)

Mechanisms of miR-128-3p in inhibiting osteoblast differentiation from bone marrow-derived mesenchymal stromal cells
por: Zhang, Wen, et al.
Publicado: (2020)

ASPN Synergizes with HAPLN1 to Inhibit the Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells and Extracellular Matrix Mineralization of Osteoblasts
por: Zhou, Guohui, et al.
Publicado: (2023)

Bone marrow-derived mesenchymal stem/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades
por: Evangelista, Afrânio Ferreira, et al.
Publicado: (2018)

Role of the Osteoblast Lineage in the Bone Marrow Hematopoietic Niches
por: Wu, Joy Y, et al.
Publicado: (2009)

Osteoblast-Secreted Factors Promote Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells via VEGF/Heme-Oxygenase-1 Pathway
por: Zhang, Lian-Fang, et al.
Publicado: (2014)

Nicotine Increases Osteoblast Activity of Induced Bone Marrow Stromal Cells in a Dose-Dependent Manner: An in vitro Cell Culture Experiment
por: Daffner, Scott D., et al.
Publicado: (2012)

Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo
por: Qin, Yunhao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lptuivf5r07fp6egj2qjgdotmr